ACTIVE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
Clinical trials for ACTIVE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new ACTIVE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for ACTIVE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Kesimpta safety checked in 367 MS patients
Disease control CompletedThis study looked at the safety of Kesimpta, a drug for multiple sclerosis (MS), in 367 people with relapsing-remitting MS or active secondary progressive MS. Researchers tracked side effects and how doctors rated symptom changes. The goal was to monitor real-world use, not to te…
Matched conditions: ACTIVE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 20, 2026 12:08 UTC
-
Italian MS patients show stable disability on siponimod over 3 years
Disease control CompletedThis study followed 134 adults in Italy with active secondary progressive multiple sclerosis who were prescribed siponimod as part of their routine care. Over 36 months, researchers measured how many patients had a confirmed worsening of disability or thinking skills. The goal wa…
Matched conditions: ACTIVE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC